Conclusions & Recommendations
19.6.1 - Minimizing risk to trachoma MDA participants
Conclusion/Recommendation:
TEC endorses:
• The goal of zero deaths due to choking
• The initiative presented to strengthen MDA training and the translation of training into practice to reduce risk to MDA participants.
Action:
The new dosing guidelines have been fully rolled out; all ICTC members and national programs have adopted them in their programs. David Addiss will update TEC participants during TEC20 about the consultation in Ethiopia to minimize risk to MDA participants.
TEC 19
2018
dosing
19.7.1 - Analysis of areas not reaching the TF elimination threshold
Conclusion/Recommendation:
TEC recommends that ITI identify the key programmatic questions, develop an analysis plan for review by TEC, and carry out analyses using existing data from areas not reaching the TF elimination threshold.
Action:
Jeremiah Ngondi and Kristen Renneker will update TEC20 participants with their proposed analysis plans for feedback.
TEC 19
2018
end game, persistence, recommendations for ITI management, TEC meeting management
19.8.1 - ITI Supply Chain - 1
Conclusion/Recommendation:
TEC commends the ITI Supply Chain team for their ongoing health systems strengthening efforts through supply chain capacity building. TEC recommends that ITI create and implement a proactive, systematic supply chain strengthening plan, including formal documentation of preferred practices and development of materials that could be shared with other NTD programs.
Action:
ITI’s Supply Chain team will present their draft plans at TEC20 for feedback.
TEC 19
2018
supply chain, recommendations for ITI management
19.8.2 - ITI Supply Chain - 1
Conclusion/Recommendation:
TEC recommends that ITI review existing country supply chain data and identify conditions that could predict future supply chain challenges, and prioritize those countries for proactive assessments.
Action:
ITI’s Supply Chain team will present their draft plans at TEC20 for feedback.
TEC 19
2018
supply chain, recommendations for ITI management
19.9.1 - ITI Supply Chain – 2
Conclusion/Recommendation:
TEC recommends that in addition to their supply chain capacity building among Ministry staff, ITI work with implementing partners in recipient countries to strengthen their capacity to identify and respond to supply chain issues.
Action:
TEC recommends that in addition to their supply chain capacity building among Ministry staff, ITI work with implementing partners in recipient countries to strengthen their capacity to identify and respond to supply chain issues.
TEC 19
2018
supply chain, recommendations for ITI management
19.9.2 - ITI Supply Chain – 2
Conclusion/Recommendation:
TEC commends the ITI Supply Chain team for its diligent “above and beyond” follow-up on in-country supply chain issues that have arisen.
Action:
No action required
TEC 19
2018
supply chain
19.9.3 - ITI Supply Chain – 2
Conclusion/Recommendation:
TEC recommends that ITI Supply Chain review the Nigeria Zithromax® Accountability Action Plan and determine whether it would be applicable for other countries.
Action:
TEC recommends that ITI Supply Chain review the Nigeria Zithromax® Accountability Action Plan and determine whether it would be applicable for other countries.
TEC 19
2018
Nigeria
supply chain, recommendations for ITI management
18.1.1 - General Recommendations to ITI
Conclusion/Recommendation:
TEC notes that it would be useful to explore the impact of skipped treatments on trachoma outcomes by considering conducting early impact surveys rather than continued treatments. Information from such an exploration could advise future TEC decisions regarding requests in areas with skipped treatments, for reasons including insecurity, force majeure, etc.
Action:
There are not yet enough skipped treatments to complete this analysis but ITI will continue to monitor this.
TEC 18
2018
research, alternative treatment strategies, insecurity, recommendations for ITI management
18.1.2 - General Recommendations to ITI
Conclusion/Recommendation:
TEC recommends to ITI Supply Chain team to analyze treatments shipped versus distributed separated into POS and tablets to better understand average dosing by presentation and therefore the discrepancy between treatments shipped and distributed.
Action:
ITI Supply Chain Team is working on the analysis of treatments shipped versus distributed for countries with high variance and will report on this at TEC 20.
TEC 18
2018
supply chain, dosing, recommendations for ITI management
18.1.3 - General Recommendations to ITI
Conclusion/Recommendation:
TEC acknowledges the enormous progress of National Programs and the commitment of countries and their progress in reducing the burden of trachoma, resulting in lower Zithromax® requests for the first time.
Action:
This is noted, and ITI will seek input from TEC on if and how this affects ITI’s strategic direction for the coming years.
TEC 18
2018
end game